Global /Thailand /Healthcare /Biotechnology /MEDEZE

Medeze Group PCL

MEDEZE

• SET: MEDEZE • Delayed

6.10THB 0%

0.1867 USD

As of 5 June 2026, Medeze Group PCL has a market cap of $200.62M USD, ranking #21046 globally and #208 in Thailand. It ranks #1892 in the Healthcare sector, and #363 in the Biotechnology industry.

Global Rank

21046

Country Rank

208

Sector Rank

1892

Industry Rank

363

Key Stats

Market Cap

$200.62MUSD

6.57B THB

Enterprise Value

$150.4MUSD

4.91B THB

Revenue (TTM)

$23.72MUSD

776.41M THB

EBITDA (TTM)

$7.59MUSD

247.94M THB

Net Income (TTM)

$6.0MUSD

196.38M THB

EBITDA Margin

32%

Profit Margin

25%

PE Ratio

33.4

Forward PE

19.5

PS Ratio

8.5

PB Ratio

2.3

EV/EBITDA

19.2

Company Profile

Country (HQ)

Thailand

Sector

Healthcare

Industry

Biotechnology

CEO

Veerapol Khemarangsan open_in_new

Employees

200

Founded

2010

Website

medezegroup.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-0.8%	0.8%	-0.8%	-8.9%	-3.1%	-19%	-54%	-54%

News

Markets

Exchange	Ticker	Price	Quotes
Stock Exchange of Thailand (SET / BKK) MIC: XBKK PRIMARY	MEDEZE บริษัท เมดีซ กรุ๊ป จำกัด (มหาชน) ISIN: THC430010007 Shares Out.: Shares Outstanding: 1.068B¹ Shares Float: 201.972M² TV: TradingView: SET: MEDEZE SA: Stock Analysis: BKK: MEDEZE YF: Yahoo Finance: MEDEZE.BK GF: Google Finance: BKK: MEDEZE BA: Barron's: MEDEZE MS: Morningstar: XBKK: MEDEZE	6.10 THB	TV: TradingView: SET: MEDEZE SA: Stock Analysis: BKK: MEDEZE YF: Yahoo Finance: MEDEZE.BK GF: Google Finance: BKK: MEDEZE BA: Barron's: MEDEZE MS: Morningstar: XBKK: MEDEZE

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Medeze Group PCL

Medeze Group Public Company Limited engages in collection and storage of stem cells for use in medication in Thailand, Vietnam, Cambodia, Philippines, and internationally. The company operates through four segments: Stem Cells; Natural Killer Cells; Others; and Sales of Products. It also provides sorting, cultivation, and development of stem cells; testing services to test the performance and count the number of natural killer cells. In addition, the company is involved in research, develops, and collects data on all types of human cellular activities and medical laboratory tests. Further, the company sells dietary supplements, cosmetics, and dermo cosmetics. Medeze Group Public Company Limited was founded in 2010 and is based in Nakhon Pathom, Thailand.

Similar Companies

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 91K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 80K%	19.0	United States
argenx SE EBR: ARGX	$48.01B 41.39B EUR 24K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$44.36B 68.19T KRW 22K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.98B 60.27B AUD 21K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.55B 33.71B CHF 21K%	37.2	Switzerland

chevron_leftBack